Clinical Trial Update: Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports safety, preliminary efficacy, and pharmacokinetics data for ASN001 in metastatic castration-resistant prostate cancer. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ASN001

Snippet

Sponsor: Asana BioSciences | Conditions: Cancer of the Prostate, Neoplasms, Prostate | Phase 1 | Status: TERMINATED